Cowen Stock Forecast, Price & News

Cowen (NASDAQ:COWN) Frequently Asked Questions

Is Cowen a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cowen in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Cowen stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in COWN, but not buy additional shares or sell existing shares.
View analyst ratings for Cowen or view top-rated stocks.

How has Cowen's stock price been impacted by COVID-19?

Cowen's stock was trading at $11.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, COWN shares have increased by 216.4% and is now trading at $36.77.
View which stocks have been most impacted by COVID-19.

When is Cowen's next earnings date?

Cowen is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for Cowen.

How were Cowen's earnings last quarter?

Cowen Inc. (NASDAQ:COWN) announced its quarterly earnings results on Thursday, October, 28th. The financial services provider reported $1.32 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.22 by $0.10. The financial services provider earned $359.06 million during the quarter, compared to analysts' expectations of $336.73 million. Cowen had a net margin of 16.97% and a trailing twelve-month return on equity of 31.20%. During the same quarter last year, the firm posted $1.25 earnings per share.
View Cowen's earnings history.

How often does Cowen pay dividends? What is the dividend yield for Cowen?

Cowen announced a quarterly dividend on Wednesday, October 27th. Stockholders of record on Wednesday, December 1st will be paid a dividend of $0.10 per share on Wednesday, December 15th. This represents a $0.40 annualized dividend and a dividend yield of 1.09%. The ex-dividend date is Tuesday, November 30th.
View Cowen's dividend history.

Is Cowen a good dividend stock?

Cowen pays an annual dividend of $0.40 per share and currently has a dividend yield of 1.06%. Cowen has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Cowen is 4.12%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cowen will have a dividend payout ratio of 5.82% next year. This indicates that Cowen will be able to sustain or increase its dividend.
View Cowen's dividend history.

When did Cowen's stock split? How did Cowen's stock split work?

Cowen's stock reverse split before market open on Monday, December 5th 2016. The 1-4 reverse split was announced on Wednesday, November 9th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 2nd 2016. An investor that had 100 shares of Cowen stock prior to the reverse split would have 25 shares after the split.

What price target have analysts set for COWN?

2 brokers have issued 1 year price targets for Cowen's stock. Their forecasts range from $35.00 to $60.00. On average, they expect Cowen's share price to reach $46.00 in the next year. This suggests a possible upside of 25.1% from the stock's current price.
View analysts' price targets for Cowen or view top-rated stocks among Wall Street analysts.

Who are Cowen's key executives?

Cowen's management team includes the following people:

• Jeffrey Marc Solomon, Chairman & Chief Executive Officer (LinkedIn Profile)
• John Holmes, Chief Operating Officer & Managing Director (LinkedIn Profile)
• Stephen A. Lasota, Chief Financial Officer
• Robert Fagin, Managing Director & Head-Research
• Elizabeth Flisser Rosman, Head-Investment Management

What is Jeffrey Solomon's approval rating as Cowen's CEO?

16 employees have rated Cowen CEO Jeffrey Solomon on Glassdoor.com. Jeffrey Solomon has an approval rating of 100% among Cowen's employees. This puts Jeffrey Solomon in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Cowen's key competitors?

Some companies that are related to Cowen include Morgan Stanley (MS), Charles Schwab (SCHW), The Goldman Sachs Group (GS), Raymond James (RJF), LPL Financial (LPLA), Stifel Financial (SF), Evercore (EVR), Lazard (LAZ), BGC Partners (BGCP), Piper Jaffray Companies (PJC), Oppenheimer (OPY), Greenhill & Co., Inc. (GHL), FBR & Co. (FBRC) and Global Brokerage (GLBR).
View all of COWN's competitors.

What other stocks do shareholders of Cowen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cowen investors own include Crown Castle International (CCI), (CGC), OPKO Health (OPK), Advanced Micro Devices (AMD), Abbott Laboratories (ABT), Corbus Pharmaceuticals (CRBP), Raytheon Technologies (RTX), AbbVie (ABBV), Ampio Pharmaceuticals (AMPE) and KushCo (KSHB).

What is Cowen's stock symbol?

Cowen trades on the NASDAQ under the ticker symbol "COWN."

Who are Cowen's major shareholders?

Cowen's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.90%), Dimensional Fund Advisors LP (4.82%), Millennium Management LLC (3.10%), Heartland Advisors Inc. (1.99%), Geode Capital Management LLC (1.86%) and Two Sigma Advisers LP (1.58%). Company insiders that own Cowen stock include Brett H Barth, Jeffrey M Solomon, John J Holmes, Lawrence E Leibowitz, Owen S Littman, Stephen Lasota and Terren S Peizer.
View institutional ownership trends for Cowen.

Which institutional investors are selling Cowen stock?

COWN stock was sold by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Voya Investment Management LLC, Two Sigma Investments LP, Credit Suisse AG, Thrivent Financial for Lutherans, Raymond James & Associates, Two Sigma Advisers LP, and Goldman Sachs Group Inc.. Company insiders that have sold Cowen company stock in the last year include Jeffrey M Solomon, John J Holmes, Owen S Littman, Stephen Lasota, and Terren S Peizer.
View insider buying and selling activity for Cowen or view top insider-selling stocks.

Which institutional investors are buying Cowen stock?

COWN stock was purchased by a variety of institutional investors in the last quarter, including Millennium Management LLC, Private Advisor Group LLC, PEAK6 Investments LLC, Healthcare of Ontario Pension Plan Trust Fund, Schonfeld Strategic Advisors LLC, Gyon Technologies Capital Management LP, Allianz Asset Management GmbH, and Morgan Stanley. Company insiders that have bought Cowen stock in the last two years include Brett H Barth, Jeffrey M Solomon, Lawrence E Leibowitz, and Owen S Littman.
View insider buying and selling activity for Cowen or or view top insider-buying stocks.

How do I buy shares of Cowen?

Shares of COWN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cowen's stock price today?

One share of COWN stock can currently be purchased for approximately $36.77.

How much money does Cowen make?

Cowen has a market capitalization of $1.00 billion and generates $1.44 billion in revenue each year. The financial services provider earns $216.36 million in net income (profit) each year or $9.71 on an earnings per share basis.

How many employees does Cowen have?

Cowen employs 1,364 workers across the globe.

When was Cowen founded?

Cowen was founded in 1994.

What is Cowen's official website?

The official website for Cowen is www.cowen.com.

Where are Cowen's headquarters?

Cowen is headquartered at 599 LEXINGTON AVENUE, NEW YORK NY, 10022.

How can I contact Cowen?

Cowen's mailing address is 599 LEXINGTON AVENUE, NEW YORK NY, 10022. The financial services provider can be reached via phone at (646) 562-1010, via email at [email protected], or via fax at 646-562-1861.